Host-response therapeutics for periodontal diseases

Area of Science:

• Oral biology and Periodontology
• Biochemistry of tissue degradation
• Therapeutic strategies in dentistry

Background:

• Periodontal diseases stem from Gram-negative biofilms, triggering host responses and tissue destruction.
• Osteoclast-derived mediators, including matrix metalloproteinases (MMPs), drive the degradation of alveolar bone and connective tissues.
• Understanding these downstream factors is crucial for developing effective periodontal treatments.

Purpose of the Study:

• To review osteoclast downstream factors responsible for periodontal tissue degradation.
• To discuss therapeutic approaches targeting MMP inhibition and bone preservation.
• To highlight the potential of chair-side diagnostic tests for periodontal health assessment.

Main Methods:

• Literature review focusing on osteoclast mediators and periodontal tissue destruction.
• Analysis of therapeutic strategies including MMP inhibitors, tetracyclines, and bisphosphonates.
• Evaluation of diagnostic tools for assessing MMP activity and tissue damage.

Main Results:

• Matrix metalloproteinases (MMPs), cathepsins, and osteoclast-derived enzymes are key drivers of tissue destruction.
• MMP inhibitors, chemically modified tetracyclines, and bisphosphonates show promise in managing periodontal disease.
• Rapid chair-side tests for MMP-8 and collagen fragments offer non-invasive diagnostic potential.

Conclusions:

• Targeting MMPs and employing bone-preservation strategies are vital for periodontal management.
• Non-invasive diagnostic tests can aid in monitoring tissue health and disease progression.
• These approaches are particularly relevant for high-risk patients prone to disease reactivation.